#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyruvate kinase deficiency anaemia Follicle centre lymphoma follicular grade I II – III refractory Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Antisynthetase syndrome Pancreatic neuroendocrine tumour Spina bifida Neuroendocrine carcinoma Anti-glomerular basement membrane disease Primary adrenal insufficiency Choroid melanoma Bronchopulmonary aspergillosis Bladder cancer Mucous membrane pemphigoid Chronic inflammatory demyelinating polyradiculoneuropathy Erythema multiforme More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Diagnostics Primary biliary cholangitis – Life with Disease Hairy cell leukaemia – Basic Information Medulloblastoma recurrent – Diagnostics Mucopolysaccharidosis III Hereditary neuropathic amyloidosis – Trials in Disease Nephroblastoma – Treatment Breast angiosarcoma – Treatment Pleural mesothelioma malignant – Trials in Disease Cytokine release syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Anidulafungin Abrocitinib Gallium (68Ga) Tafamidis Mesalazine Carisbamate L-Ascorbic Acid Hydrocortisone Ph. Eur. LUNRESERTIB Belantamab Mafodotin Gad20-209-Fsp-A4 Isoflurane Givinostat Lovastatin Evg321 Elranatamab Exenatide Inclisiran Sodium Izokibep Opium, Standardized Powdered More therapies…

    Learn about Your Condition

    Hypoalbuminaemia Labour pain Pulmonary tuberculosis Inclusion body myositis Cervix carcinoma Head and neck cancer stage III Embolism Hypothyroidism Netherton's syndrome Graft infection Bile duct adenocarcinoma Triple negative breast cancer Sepsis Postprandial hypoglycaemia Hypertension More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • A Study to Evaluate the Safety and Effectiveness of Ritlecitinib Tosilate in Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    2 1
    Germany Greece Poland Spain

  • A study to evaluate the safety and effectiveness of BO-112 injections in patients with resectable primary basal cell carcinoma.

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Basal cell carcinoma
    Investigated Drugs:
    • Polyinosinic:polycytidylic Acid
    Spain

  • Evaluation of Long-term Safety and Efficacy of Enpatoran in Subacute Cutaneous, Discoid, and Systemic Lupus Erythematosus Post-WILLOW Study Completion

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Enpatoran
    Bulgaria Greece Poland Romania Spain

  • A study to examine how the body processes and removes DC-806 in healthy male volunteers

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Dc-806
    • [14C] DC-806
    The Netherlands

  • Safety and Tolerability of Topical Iodine (DLQ03) in Patients with Mild to Moderate Atopic Dermatitis Colonized with Staphylococcus aureus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    The Netherlands

  • A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • HUMAN IGG1 BISPECIFIC MONOCLONAL ANTIBODY AGAINST KALLIKREIN-5 AND KALLIKREIN-7
    Bulgaria Czechia Hungary Poland
Previous Page
1 … 30 31 32 33 34 … 66
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!